Ochsner Health is the leading nonprofit healthcare provider in the Gulf South. Ochsner inspires healthier lives and stronger communities through our mission to serve, heal, lead, educate and innovate.
Ochsner Lafayette General Medical Center, the largest full-service medical center in Acadiana, was named one of Forbes Top Hospitals 2026, the publication’s first national assessment of hospital performance.
VIEW THIS ARTICLE ON Acadiana ProfileDr. Chip Lavie joined Ochsner Health dietitian, Molly Kimball, to discuss modern heart health.
VIEW THIS ARTICLE ON New Orleans MagazineOchsner Neuroscience Institute is marking the 10-year anniversary of its Amyotrophic Lateral Sclerosis (ALS) Center, a recognized Center of Excellence dedicated to providing advanced, multidisciplinary care.
VIEW THIS ARTICLE ON Biz New OrleansAs 2026 begins, Ochsner Health physicians recommend adults take a proactive approach to preventive care by scheduling health screenings designed to detect diseases early, often before symptoms appear. From cardiovascular and metabolic assessments to cancer and age-related exams, many evaluations play a critical role in improving health outcomes.
VIEW THIS ARTICLE ON The Times-PicayuneThe following hospitals and health systems are known for their exceptional cardiovascular care, strong patient outcomes and their use of life-saving technologies. These heart programs also lead the way in cardiology research, driving discoveries that are shaping and advancing the field.
VIEW THIS ARTICLE ON Becker's Hospital ReviewThe University of Queensland Medical School – Ochsner Health (UQ-Ochsner MD) honored its doctors-in-training on Jan. 10 at its 16th annual White Coat Ceremony, a rite of passage for medical students held to emphasize the importance of compassionate patient care from the start of medical training.
VIEW THIS ARTICLE ON Biz New OrleansOchsner MD Anderson Cancer Center has begun offering a newly approved, non-invasive treatment for certain liver tumors, making it one of a limited number of hospitals nationwide to provide the technology.
VIEW THIS ARTICLE ON New Orleans City BusinessIn October 2025, the FDA approved an updated label update for capecitabine mandating DPYD genetic testing before initiating treatment, unless urgent. In a Q&A with Pharmacy Times, Serena Mitaly, PharmD, a system clinical pharmacogenomics pharmacist with Ochsner Health, discussed what this label update means for practicing pharmacists and their patients.
VIEW THIS ARTICLE ON Pharmacy TimesTimothy Riddell, MD, was named executive vice president and COO of New Orleans-based Ochsner Health.
VIEW THIS ARTICLE ON Becker's Hospital ReviewAt Ochsner Health, Dr. Mizrahi found a professionally fulfilling role that matched his subspecialty interests and commitment to collaborative care.
VIEW THIS ARTICLE ON American Medical Association